de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med . 1994;;331:342-346.
Nwanyanwu OC, Chu SY, Green TA, Buehler JW, Berkelman RL. Acquired immunodeficiency syndrome in the United States associated with injecting drug use. Am J Drug Alcohol Abuse . 1993;;19:399-408.
Mofenson L. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis . 1994;;5:252-265.
Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med . 1994;;331:1173-1180.
Patrizio P, Ord T, Silber SJ, Asch RH. Cystic fibrosis mutations impair the fertilization rate of epididymal sperm from men with congenital absence of the vas deferens. Hum Reprod . 1993;;8:1259-1263.
Patrizio P, Ord T, Silber SJ, Asch RH. Correlation between epididymal length and fertilization rate in women with congenital absence of the vas deferens. Fertil Steril . 1994;;61:265-268.
Gabay M, Wolfe SM. Unnecessary Cesarean Sections: Curing a National Epidemic . Washington, DC: Public Citizen's Health Research Group, Public Citizens Publications; May 1994;.
Miller DA, Diaz FG, Paul RH. Vaginal birth after cesarean section: a ten year experience. Obstet Gynecol . 1994;;84:255-258.
Carr BR, Marshburn PB, Weatherall PT, et al. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab . 1993;;76:1217-1223.
Friedman AJ, Daly M, Juneau Norcross M, et al. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin 'add-back' regimens for women with leiomyomata uteri. J Clin Endocrinol Metab . 1993;;76:1439-1445.
Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol . 1993;;168:1759-1765.
Findlay I, Cunningham D, Dargie H. Coronary heart disease, the menopause, and hormone replacement therapy. Br Heart J . 1994;;71:213-214.
The Writing Group for the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA . 1995;;273:199-208.
Nachtigall MJ, Smilen SW, Nachtigall RD, et al. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy. Obstet Gynecol . 1992;;80:827-830.